Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

962
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
962
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

787
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
787
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

180
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
180
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

74
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
74

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarkers in QuantiFERON Supernatants May Help Distinguish Latent Tuberculosis Infection From Active Tuberculosis: Preliminary Report.

Mediators of inflammation·2026
Same author

Alarming levels of fluoroquinolone resistance among MDR-TB patients in Poland: molecular and phenotypic analysis.

Frontiers in cellular and infection microbiology·2026
Same author

Time-dependent effects of interleukin-1 blockade by anakinra in myocarditis and inflammatory cardiomyopathy.

European journal of heart failure·2026
Same author

CT Quantification of Intraventricular Hemorrhage Volume in Poor-Grade Aneurysmal Subarachnoid Hemorrhage: Impact on Mortality and Long-Term Disability.

Neurocritical care·2026
Same author

Catalytic and Antitubercular Activities of Multifunctional Copper(II)-Schiff Base Complexes: Insights into Structure, Theoretical Calculations, and Physicochemical Behavior.

Inorganic chemistry·2026
Same author

Diagnostic Assays for TB Disease and Drug Resistance Detection-Advances and Latest WHO Recommendations.

Cold Spring Harbor perspectives in medicine·2026

Related Experiment Video

Updated: Apr 21, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.2K

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.

Paolo Miotto1, Andrea M Cabibbe2, Silke Feuerriegel

  • 1Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy miotto.paolo@hsr.it.

Mbio
|October 23, 2014
PubMed
Summary

Molecular identification of pyrazinamide resistance (PZA(r)) in Mycobacterium tuberculosis is challenging due to diverse pncA gene mutations. This study classified pncA variants, enabling development of accurate molecular diagnostic tests for PZA resistance.

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

18.4K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.5K

Related Experiment Videos

Last Updated: Apr 21, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.2K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

18.4K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.5K

Area of Science:

  • Microbiology
  • Genetics
  • Molecular Diagnostics

Background:

  • Pyrazinamide (PZA) is a crucial first-line tuberculosis drug.
  • Resistance to PZA is often mediated by mutations in the pncA gene.
  • Current phenotypic drug susceptibility testing for PZA is unreliable and technically difficult.

Purpose of the Study:

  • To investigate pncA gene variations in Mycobacterium tuberculosis.
  • To correlate pncA mutations with pyrazinamide resistance (PZA(r)).
  • To classify pncA variants for improved molecular diagnostic assay development.

Main Methods:

  • Sequencing of the pncA gene in 1,950 clinical isolates of Mycobacterium tuberculosis.
  • Correlation of pncA sequence variations with phenotypic resistance, enzymatic activity, and structural data.
  • Classification of identified genetic variants based on their association with PZA resistance.

Main Results:

  • Identified 280 genetic variants in the pncA gene.
  • Classified variants into four categories based on their predictive value for PZA resistance.
  • Determined that high-confidence resistance mutations are present in over 70% of PZA(r) strains.

Conclusions:

  • A molecular diagnostic assay targeting specific pncA variants can accurately detect PZA resistance.
  • The diagnostic accuracy is estimated to be between 89.5% and 98.8%.
  • This approach offers a breakthrough for rapid and reliable PZA resistance detection, aiding treatment decisions.